Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

88 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A comparison of the effects of pioglitazone and rosiglitazone combined with glimepiride on prothrombotic state in type 2 diabetic patients with the metabolic syndrome.
Derosa G, Cicero AF, Gaddi A, Ragonesi PD, Piccinni MN, Fogari E, Salvadeo S, Ciccarelli L, Fogari R. Derosa G, et al. Among authors: fogari e, fogari r. Diabetes Res Clin Pract. 2005 Jul;69(1):5-13. doi: 10.1016/j.diabres.2004.10.007. Epub 2004 Dec 29. Diabetes Res Clin Pract. 2005. PMID: 15955382 Clinical Trial.
Long-term effects of glimepiride or rosiglitazone in combination with metformin on blood pressure control in type 2 diabetic patients affected by the metabolic syndrome: a 12-month, double-blind, randomized clinical trial.
Derosa G, Cicero AF, Gaddi AV, Ciccarelli L, Piccinni MN, Salvadeo S, Pricolo F, Fogari E, Ghelfi M, Ferrari I, Fogari R. Derosa G, et al. Among authors: fogari e, fogari r. Clin Ther. 2005 Sep;27(9):1383-91. doi: 10.1016/j.clinthera.2005.09.003. Clin Ther. 2005. PMID: 16291411 Clinical Trial.
Metabolic and antihypertensive effects of moxonidine and moxonidine plus irbesartan in patients with type 2 diabetes mellitus and mild hypertension: a sequential, randomized, double-blind clinical trial.
Derosa G, Cicero AF, D'Angelo A, Fogari E, Salvadeo S, Gravina A, Ferrari I, Fassi R, Fogari R. Derosa G, et al. Among authors: fogari e, fogari r. Clin Ther. 2007 Apr;29(4):602-10. doi: 10.1016/j.clinthera.2007.03.015. Clin Ther. 2007. PMID: 17617283 Clinical Trial.
Effects of insulin therapy with continuous subcutaneous insulin infusion (CSII) in diabetic patients: comparison with multi-daily insulin injections therapy (MDI).
Derosa G, Maffioli P, D'Angelo A, Salvadeo SA, Ferrari I, Fogari E, Mereu R, Gravina A, Palumbo I, Randazzo S, Cicero AF. Derosa G, et al. Among authors: fogari e. Endocr J. 2009;56(4):571-8. doi: 10.1507/endocrj.k08e-330. Epub 2009 Apr 7. Endocr J. 2009. PMID: 19352055 Free article. Clinical Trial.
88 results